#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Elisabeth Averwerser Email
Head Business Unit Hemophilia % Hereditary angioedema . CSLS
,
Locatione*******************@csl.com.au
Primary EmailHow to contact Elisabeth Averwerser
Join and see Elisabeth's contact info for free!Current Roles
Employees:
25475Revenue:
$3.9BAbout
Delivering on promises is what we do at CSL. More than a century ago, we made a promise to save lives and protect the health of people who were stricken with a range of serious and chronic medical conditions. Today, as a leading global biotechnology company, that same promise has never been stronger.\n\nWe provide life-saving medicines in more than 60 nations with over 17,000 employees worldwide. CSL is driven to develop and deliver a broad range of life-saving medicines to treat disorders such as haemophilia and primary immune deficiencies, and vaccines to prevent influenza. Our therapies are also used in cardiac surgery, organ transplantation and burn treatment.\n\nInnovation has been in the DNA of CSL since our beginning in 1916 and continues as the core of everything we do today. Innovation spans our company — reflected in our 1,100 dedicated scientists who focus on solving patients’ unmet needs every day.\n\nAs a global leader, CSL collaborates and supports patient and medical communities by improving access to therapies, advancing scientific knowledge, supporting future medical researchers, and engaging our staff in the support of local communities.\nOur world-class commercial operation, combined with a large and focused R&D team and operational excellence, enable us to accurately identify, successfully develop, and dependably deliver innovations that patients and providers want.\n\nCSL has earned a reputation as a passionate yet responsible organization driven to care for patients and deliver on its commitments. Today, our future has never looked brighter.CSLS Address
45 Poplar Rdnull, null
UK